Suchergebnisse - "Krupka, Christina"

PubPharm (32)

1

Integrated multiomic approach for identification of novel immunotherapeutic targets in AML

enthalten in: Biomarker research | 2022

von Köhnke, T. | Liu, X. | Haubner, S. | +6

2

Integrated multiomic approach for identification of novel immunotherapeutic targets in AML

enthalten in: Biomarker Research | 2022

von Köhnke, T. | Liu, X. | Haubner, S. | +6

3

Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody

enthalten in: Blood | 2021

von Augsberger, C. | Hänel, G. | Xu, W. | +33

CommentIn: Blood. 2021 Dec 23;138(25):2598-2599. - PMID 34940819

4

Combination of epigenetic factors and bispecific compounds targeting CD33 and CD3 in the treatment of myeloid leukemia

enthalten in: Europäisches Patentamt | 2021

von WALTER ROLAND B | SUBKLEWE MARION | KRUPKA CHRISTINA

5

Combination of epigenetic factors and bispecific compounds targeting CD33 and CD3 in the treatment of myeloid leukemia

enthalten in: Europäisches Patentamt | 2020

von WALTER ROLAND B | SUBKLEWE MARION | KRUPKA CHRISTINA

6

Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia

enthalten in: Molecular cancer therapeutics | 2020

von Brauchle, B. | Goldstein, R. | Karbowski, C. | +23

7

Combination of Epigenetic Factors And Bispecific Compounds Targeting CD33 And CD3 In the Treatment Of Myeloid Leukaemia

enthalten in: Europäisches Patentamt | 2020

von WALTER ROLAND B | SUBKLEWE MARION | KRUPKA CHRISTINA

8

ADMINISTRATION OF A BISPECIFIC CONSTRUCT BINDING TO CD33 AND CD3 FOR USE IN A METHOD FOR THE TREATMENT OF MYELOID LEUKEMIA

enthalten in: Europäisches Patentamt | 2019

von ZUGMAIER GERHARD | KUFER PETER | KISCHEL ROMAN | +2

9

Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia

enthalten in: Blood | 2018

von Herrmann, M. | Krupka, C. | Deiser, K. | +11

CommentIn: Blood. 2018 Dec 6;132(23):2425-2427. - PMID 30523124

10

Administration of a bispecific construct binding to CD33 and CD3 for use in a method for the treatment of myeloid leukemia

enthalten in: Europäisches Patentamt | 2018

von ZUGMAIER GERHARD | KUFER PETER | KISCHEL ROMAN | +2